Philippe Gabríel Steg

6 ta ish

University of Paris

1. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

   Deepak L. Bhatt, Philippe Gabríel Steg, Michael Miller +9

   Maqola20186 iqtibos

   ABIABI:AkademIndex/2026.other.057745

2. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

   Borja Ibáñez, Stefan James, Stefan Agewall +93

   MaqolaOAOchiq kirish20175 iqtibos

   ABIABI:AkademIndex/2026.other.207946

3. An international multidisciplinary consensus statement on MAFLD and the risk of CVD

   Xiaodong Zhou, Giovanni Targher, Christopher D. Byrne +45

   MaqolaOAOchiq kirish20232 iqtibos

   ABIABI:AkademIndex/2026.other.015805

4. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up

   Behnood Bikdeli, Mahesh V. Madhavan, David Jiménez +43

   Sharh maqolaOAOchiq kirish20202 iqtibos

   ABIABI:AkademIndex/2026.other.208175

5. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure

   Lori B. Daniels, Paul Clopton, Vikas Bhalla +17

   Maqola20062 iqtibos

   ABIABI:AkademIndex/2026.other.295674

6. Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk

   Benjamin M. Scirica, Deepak L. Bhatt, Eugene Braunwald +10

   Maqola20162 iqtibos

   ABIABI:AkademIndex/2026.other.679649